🟢 Telix Pharmaceuticals is trading 5% up in pre-market after announcing September 22 R&D Day

Telix Pharmaceuticals is trading 5.26% up at $11.20 after announcing on August 6, 2026, that it will host an R&D Day in New York on September 22.

• The event may have renewed attention on its oncology pipeline and commercial radiopharmaceutical franchise.
• No new earnings report was announced overnight; first-half 2026 results remain scheduled for August 20.
• Broader healthcare strength also supports the move, with XLV up 1.27% pre-market.